GlassScriptPhysician profile
Reginald Brent Harbin
NPI 1154352599
$25,558.60
in general payments reported to CMS, 2019-2025
22 companies · $161 in 2025
The $161 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,013 · 2020: $486 · 2021: $9,183 · 2022: $9,715 · 2023: $3,674 · 2024: $326 · 2025: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,485 · Food and Beverage: $1,676.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,484.93 |
| Food and Beverage | $1,676.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $15,984.72 | 2021-2023 | Jublia |
| Medical Device Business Services, INC. | $3,288.13 | 2022-2023 | Na |
| Musculoskeletal Transplant Foundation INC. | $1,709.53 | 2019-2020 | |
| Smith+Nephew, INC. | $1,575.67 | 2019-2025 | Grafix Pl, Stravix Pl, Grafix |
| Treace Medical Concepts, INC. | $1,204.85 | 2021-2022 | |
| Wright Medical Technology, INC. | $400.05 | 2019 | |
| Stryker Corporation | $262.42 | 2020-2021 | |
| Nevro Corp. | $234.23 | 2023-2024 | Senza |
| Organogenesis INC. | $160.81 | 2021-2022 | |
| Sanara Medtech INC. | $148.23 | 2022-2024 | Celleraterx, Biasurge |
| Depuy Synthes Sales INC. | $143.02 | 2022-2023 | Hammerlock |
| Medtronic, INC. | $77.45 | 2022-2023 | Intellis Adaptivestim |
| Biocomposites INC | $71.43 | 2025 | Stimulan |
| Acera Surgical, INC. | $69.13 | 2020 | |
| Abbvie INC. | $47.36 | 2022-2023 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $42.24 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Paratek Pharmaceuticals, INC. | $34.22 | 2022-2023 | Nuzyra |
| Djo, LLC | $28.54 | 2025 | Cmf |
| Convatec INC. | $27.47 | 2023 | |
| Melinta Therapeutics, LLC | $21.97 | 2021 | |
| Ethicon US, LLC | $15.39 | 2022 | |
| Paragon 28, INC. | $11.74 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Reginald Harbin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.